A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High-Risk Patients With Hypertriglyceridemia and on Statin
Clinical trial NCT01492361 · COMPLETED
Trial details
- NCT number
- NCT01492361
- Sponsor
- Amarin Pharma Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2018-05-01
- Enrollment
- 8179
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.